Blau Farmacêutica S.A. (BVMF:BLAU3)

Blau Farmacêutica Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,185	2,337	2,916	4,681	6,530	-
Market Cap Growth	-14.58%	-19.87%	-37.70%	-28.32%	-	-
Enterprise Value	2,404	2,442	3,041	4,231	6,028	-
Last Close Price	12.30	12.81	15.47	24.33	32.65	-
PE Ratio	6.75	10.76	11.67	12.88	20.08	-
Forward PE	7.15	8.13	12.65	11.36	15.20	-
PS Ratio	1.24	1.33	2.12	3.33	4.78	-
PB Ratio	0.94	1.09	1.46	2.58	3.99	-
P/TBV Ratio	1.02	1.19	1.60	2.82	4.39	-
P/FCF Ratio	13.18	6.41	40.99	160.06	1100.43	-
P/OCF Ratio	5.61	4.61	13.22	27.23	42.37	-
PEG Ratio	0.43	0.45	4.22	0.58	0.75	-
EV/Sales Ratio	1.36	1.39	2.22	3.01	4.41	-
EV/EBITDA Ratio	5.17	6.44	6.36	9.01	12.70	-
EV/EBIT Ratio	5.75	7.21	6.78	9.36	13.20	-
EV/FCF Ratio	14.50	6.70	42.74	144.69	1015.90	-
Debt / Equity Ratio	0.23	0.26	0.31	0.17	0.23	3.12
Debt / EBITDA Ratio	1.17	1.45	1.26	0.66	0.79	1.70
Debt / FCF Ratio	3.29	1.53	8.55	10.66	63.11	4.80
Asset Turnover	0.52	0.54	0.49	0.58	0.76	1.18
Inventory Turnover	1.68	1.78	1.47	1.50	1.88	2.43
Quick Ratio	1.37	1.99	2.75	2.99	3.70	1.30
Current Ratio	2.90	3.12	4.63	4.52	4.95	2.20
Return on Equity (ROE)	14.32%	10.30%	12.98%	20.88%	34.89%	104.43%
Return on Assets (ROA)	7.62%	6.55%	10.09%	11.71%	15.85%	24.19%
Return on Capital (ROIC)	9.48%	7.97%	11.84%	13.66%	19.54%	33.38%
Return on Capital Employed (ROCE)	14.20%	11.80%	16.50%	21.30%	23.00%	42.80%
Earnings Yield	14.85%	9.30%	8.57%	7.76%	4.98%	-
FCF Yield	7.59%	15.60%	2.44%	0.63%	0.09%	-
Dividend Yield	2.96%	-	2.48%	2.65%	-	-
Payout Ratio	19.81%	25.83%	26.48%	37.30%	32.02%	129.32%
Buyback Yield / Dilution	-2.06%	-	0.08%	0.87%	-13.84%	-4.39%
Total Shareholder Return	0.90%	-	2.56%	3.52%	-13.84%	-4.39%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.